Kathryn H. Gessner, MD, PhD, outlines the clinical scenarios in which she finds genomic testing most useful.| Urology Times
This bill would cut funds for research projects in disease states such as prostate cancer, bladder cancer, kidney cancer, and interstitial cystitis.| Urology Times